Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)

Market Cap	11.35B
Revenue (ttm)	1.52B
Net Income (ttm)	412.89M
Shares Out	1.25B
EPS (ttm)	0.33
PE Ratio	27.91
Forward PE	30.27
Dividend	0.12 (1.27%)
Ex-Dividend Date	May 29, 2025

Volume	126,911,702
Average Volume	141,290,196
Open	9.71
Previous Close	9.08
Day's Range	8.22 - 9.71
52-Week Range	4.87 - 10.23
Beta	0.26
RSI	63.19
Earnings Date	Aug 15, 2025

About SHE:002550

Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers its products in the form of tablets, hard capsules, lyophilized powder and lyophilized powder injections, small-volume injections, and raw materials. It provides enzymes, including pancreatic kininogenase series, asparaginase series, and compound digestive enzyme capsule II; and polysaccharides products, such as nadroparin calcium, enoxaparin sodium, dalteparin sodium, and asparaginase and heparin sodium. The company ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1971
• Employees: 979
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002550

Financial Performance

In 2024, SHE:002550's revenue was 1.53 billion, a decrease of -15.88% compared to the previous year's 1.81 billion. Earnings were 356.03 million, an increase of 95.77%.